Green Mountain Coffee Roasters Inc. (NASDAQ:GMCR): After Green Mountain reported stronger-than-expected fourth-quarter results, Buckingham believes that the company is poised for significant margin expansion; the firm believes the stock has minimum downside, while investor sentiment toward the name should improve as market share losses subside or reverse in the 2014 fiscal year. The analyst keeps a Buy rating on the shares.
LinkedIn Corp. (NYSE:LNKD): FBR Capital initiated coverage of LinkedIn with a Market Perform rating; the firm believes slowing revenue momentum in fourth quarter could constrain LinkedIn’s stock performance over the near term. The analyst started shares with a Market Perform rating and $214 price target.
Biogen Idec Inc. (NASDAQ:BIIB): Jefferies expects that the European Union will grant Biogen’s Tecfidera 10 years of exclusivity on Friday based on its talks with a regulator and the firm’s analysis of preclinical and clinical data; the firm keeps a Buy rating on Biogen with a $300 price target. Jefferies says that options activity implies that the Street has placed a $15-$17 per share value on Friday’s EU Tecfidera exclusivity decision.
General Motors Co. (NYSE:GM): Buckingham expects General Motors’s earnings and cash flow to be boosted by the launch of its K2XX platform; the firm thinks the stock could react favorably to the company’s November sales results, as it estimates that its sales are outperforming the rest of the industry this month. The analyst affirms that General Motors shares should be bought at the current levels.